Close

Foghorn Therapeutics (FHTX) PT Raised to $28 at Goldman Sachs, Following Clinical Update

March 19, 2021 12:53 PM EDT Send to a Friend
Goldman Sachs analyst Paul Choi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login